PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL
Visit https://www.peervoice.com/MNN860 to view the entire programme with slides. After completing “A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL”, participants will be able to: Describe the cardiovascular (CV) safety profile of BTK inhibitors in the treatment of CLL; Outline strategies to mitigate and manage CV risks in patients with CLL on BTK inhibitors